BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

338 related articles for article (PubMed ID: 28992067)

  • 1. The uremic toxin indoxyl sulfate interferes with iron metabolism by regulating hepcidin in chronic kidney disease.
    Hamano H; Ikeda Y; Watanabe H; Horinouchi Y; Izawa-Ishizawa Y; Imanishi M; Zamami Y; Takechi K; Miyamoto L; Ishizawa K; Tsuchiya K; Tamaki T
    Nephrol Dial Transplant; 2018 Apr; 33(4):586-597. PubMed ID: 28992067
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of hepcidin ameliorates anemia and improves growth in an adenine-induced mouse model of chronic kidney disease.
    Akchurin O; Sureshbabu A; Doty SB; Zhu YS; Patino E; Cunningham-Rundles S; Choi ME; Boskey A; Rivella S
    Am J Physiol Renal Physiol; 2016 Nov; 311(5):F877-F889. PubMed ID: 27440777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AST-120 ameliorates lowered exercise capacity and mitochondrial biogenesis in the skeletal muscle from mice with chronic kidney disease via reducing oxidative stress.
    Nishikawa M; Ishimori N; Takada S; Saito A; Kadoguchi T; Furihata T; Fukushima A; Matsushima S; Yokota T; Kinugawa S; Tsutsui H
    Nephrol Dial Transplant; 2015 Jun; 30(6):934-42. PubMed ID: 25878055
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of dietary iron intake and chronic kidney disease on fibroblast growth factor 23 metabolism in wild-type and hepcidin knockout mice.
    Hanudel MR; Chua K; Rappaport M; Gabayan V; Valore E; Goltzman D; Ganz T; Nemeth E; Salusky IB
    Am J Physiol Renal Physiol; 2016 Dec; 311(6):F1369-F1377. PubMed ID: 27733366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deregulated iron metabolism in bone marrow from adenine-induced mouse model of chronic kidney disease.
    Kimura T; Kuragano T; Yamamoto K; Nanami M; Hasuike Y; Nakanishi T
    Int J Hematol; 2019 Jan; 109(1):59-69. PubMed ID: 30232784
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uremic Toxic Blood-Brain Barrier Disruption Mediated by AhR Activation Leads to Cognitive Impairment during Experimental Renal Dysfunction.
    Bobot M; Thomas L; Moyon A; Fernandez S; McKay N; Balasse L; Garrigue P; Brige P; Chopinet S; Poitevin S; Cérini C; Brunet P; Dignat-George F; Burtey S; Guillet B; Hache G
    J Am Soc Nephrol; 2020 Jul; 31(7):1509-1521. PubMed ID: 32527975
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting the hepcidin-ferroportin pathway in anaemia of chronic kidney disease.
    Sheetz M; Barrington P; Callies S; Berg PH; McColm J; Marbury T; Decker B; Dyas GL; Truhlar SME; Benschop R; Leung D; Berg J; Witcher DR
    Br J Clin Pharmacol; 2019 May; 85(5):935-948. PubMed ID: 30677788
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitors block iron absorption through direct regulation of hepcidin via the aryl hydrocarbon receptor-mediated pathway.
    Hamano H; Niimura T; Horinouchi Y; Zamami Y; Takechi K; Goda M; Imanishi M; Chuma M; Izawa-Ishizawa Y; Miyamoto L; Fukushima K; Fujino H; Tsuchiya K; Ishizawa K; Tamaki T; Ikeda Y
    Toxicol Lett; 2020 Jan; 318():86-91. PubMed ID: 31669099
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A hepcidin lowering agent mobilizes iron for incorporation into red blood cells in an adenine-induced kidney disease model of anemia in rats.
    Sun CC; Vaja V; Chen S; Theurl I; Stepanek A; Brown DE; Cappellini MD; Weiss G; Hong CC; Lin HY; Babitt JL
    Nephrol Dial Transplant; 2013 Jul; 28(7):1733-43. PubMed ID: 23345622
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bone marrow iron distribution, hepcidin, and ferroportin expression in renal anemia.
    Bârsan L; Stanciu A; Stancu S; Căpuşă C; Brătescu L; Mandache E; Radu E; Mircescu G
    Hematology; 2015 Oct; 20(9):543-52. PubMed ID: 25745821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iron sucrose ('RBT-3') activates the hepatic and renal HAMP1 gene, evoking renal hepcidin loading and resistance to cisplatin nephrotoxicity.
    Zager RA; Johnson ACM; Therapeutics R
    Nephrol Dial Transplant; 2021 Feb; 36(3):465-474. PubMed ID: 33547792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Hepcidin-Anemia Axis: Pathogenesis of Anemia in Chronic Kidney Disease.
    Nakanishi T; Kimura T; Kuragano T
    Contrib Nephrol; 2019; 198():124-134. PubMed ID: 30991414
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PCB-77 disturbs iron homeostasis through regulating hepcidin gene expression.
    Wang L; Zhang S; Lin R; Li L; Zhang D; Li X; Liu S
    Gene; 2013 Dec; 532(1):146-51. PubMed ID: 24055725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepcidin in chronic kidney disease anemia.
    Santos-Silva A; Ribeiro S; Reis F; Belo L
    Vitam Horm; 2019; 110():243-264. PubMed ID: 30798815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of Hepcidin-25 in Chronic Kidney Disease: Anemia and Beyond.
    Ueda N; Takasawa K
    Curr Med Chem; 2017; 24(14):1417-1452. PubMed ID: 28302014
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polychlorinated biphenyls (PCBs) inhibit hepcidin expression through an estrogen-like effect associated with disordered systemic iron homeostasis.
    Qian Y; Zhang S; Guo W; Ma J; Chen Y; Wang L; Zhao M; Liu S
    Chem Res Toxicol; 2015 Apr; 28(4):629-40. PubMed ID: 25686467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Misdistribution of iron and oxidative stress in chronic kidney disease.
    Nakanishi T; Kuragano T; Nanami M; Nagasawa Y; Hasuike Y
    Free Radic Biol Med; 2019 Mar; 133():248-253. PubMed ID: 29958932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduction of indoxyl sulfate by AST-120 attenuates monocyte inflammation related to chronic kidney disease.
    Ito S; Higuchi Y; Yagi Y; Nishijima F; Yamato H; Ishii H; Osaka M; Yoshida M
    J Leukoc Biol; 2013 Jun; 93(6):837-45. PubMed ID: 23362306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of iron regulatory hormone hepcidin by interferon α.
    Ichiki K; Ikuta K; Addo L; Tanaka H; Sasaki Y; Shimonaka Y; Sasaki K; Ito S; Shindo M; Ohtake T; Fujiya M; Torimoto Y; Kohgo Y
    J Gastroenterol Hepatol; 2014 Feb; 29(2):387-94. PubMed ID: 23926964
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cardiac Hepcidin Expression Associates with Injury Independent of Iron.
    van Breda GF; Bongartz LG; Zhuang W; van Swelm RP; Pertijs J; Braam B; Cramer MJ; Swinkels DW; Doevendans PA; Verhaar MC; Masereeuw R; Joles JA; Gaillard CA
    Am J Nephrol; 2016; 44(5):368-378. PubMed ID: 27771699
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.